Take two recently-approved immunotherapies for triple negative breast cancer (TNBC), put them together, and what do you get? Hopefully a new standard of care for the aggressive disease, according to ...

The Chicago Bears have the No. 3 offense in the NFL, averaging 379.8 yards per game. That bears repeating: The Chicago Bears have the No. 3 offense in the NFL. That’s through 10 weeks, too, no small ...

LOS ANGELES >> The number of whales getting tangled up in fishing nets, line, buoys and other miscellaneous rope off the coasts of the United States hit a record high in 2024, with California taking ...

This is read by an automated voice. Please report any issues or inconsistencies here. Whale entanglements in U.S. waters hit a record 95 cases in 2024, well above the historical average of 71 per year ...

It was a gray day in Panama City, one of those mornings weighed down by the clouds. The banana trees hung heavy and the grass was slick with rain. My Duke Engage group — a team of eight Duke students ...

From memorable dates to mapping out shapes in the lotto cards, Aussies are rather particular about how they play. With nearly 200 million lotto winners last year sharing $4.84 billion in prize money ...

It’s easy to make comparisons between the 2025 Chicago Bears roster to open the season and how things might have felt at this time last September. The big difference, of course, is head coach Ben ...

Pre-market futures are improving following the release of major economic numbers this morning. A drawback in EU markets this morning (Germany reported a surge in unemployment and higher inflation) ...

The new week is set to begin on a cautious note for domestic markets amid escalating tension between India and the US over tariffs. All eyes are on Russian President Vladmir Putin’s meeting with the ...

At the Stonewall National Monument in New York, where the Interior Department came under fire earlier this year for removing mentions of transgender people from the park’s website, visitors have left ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in first-line triple-negative breast cancer (TNBC), Gilead Sciences’ Trodelvy ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...